The Ministry of Industry, Trade and Tourism provisionally selected 18 projects in the call for proposals. assistance to strategic projects for industrial transition pharmaceutical industry and its sector medical deviceswith Total aid of 15.6 million euros. This call is directed towards the industrial fabric. Pioneer Health PERTEIt forms part of the Recovery, Transformation and Resilience Plan, financed by European funds. In the distribution of aid according to autonomous communities, Catalonia, Castile-La Mancha, Madrid and the Basque Country stand out.
Call giving assistance A total of 27 applications were received from 24 companies. The total amount requested between the loan and the grant was 28.8 million euros. With the publication of these provisional proposals, the processing of this aid continues and a period for possible claims is now opened for this. From the publication of the provisional proposal, applicants are given 10 working days to formulate the arguments they consider relevant.
Concern in the industry
The announcement comes at a very serious time Concern in the pharmaceutical industryA certain slowdown began to be seen after 2022, when good progress was made in exports. Spanish pharmaceutical companies are warning of a loss of competitiveness in Europe compared to the US and Asia, demanding the acceleration of procedures for changing legislation that protects industrial property and encourages innovation. According to employers’ association Farmaindustria, while 41% of new medicines were produced in Europe in the early 1990s, only 21% of them were produced in the 2017-2021 period. Public aid to the pharmaceutical industry should be aimed at modernizing production facilities, without forgetting research and clinical trials.
The new legal framework is under construction in Europe but there are still issues involved for its final draft. ” proposed revision of the legislative package Nathalie Moll, Director General of the Federation of the European Pharmaceutical Industry, said in her speech at the sector meeting, “The measures presented by the European Commission include positive aspects as well as measures that pose a serious risk for the R&D production model on the continent.” Menéndez Pelayo Santander University.
The Federation of the European Pharmaceutical Industry (Efpia), which includes Farmaindustria, together with four other organizations, signed a manifesto in which they propose proposals for a new legal framework that guarantees quality in these treatments, reduces uncertainty and protects patients. They particularly draw attention to the regulation of advanced treatment drugs.
Three axes of development
Inside pharmaceutical industry The Spanish agreed that these were three of the key elements that would stimulate activity. Enable access to innovation, improve lead times and ensure the availability of innovative medicines, primarily through a stable, open, agile and predictable framework. Secondly, to consolidate Spain’s leadership in biomedical R&D by promoting relationships between laboratories and clinical practices, with special emphasis on translational research. Third, strengthen the productive fabric by relying on jobs, growth and less dependence on powers like India or China for essential medicines. “We have been working on the Strategic Plan for the Pharmaceutical Industry for months and we must continue to promote it so that it becomes a reality soon,” said its President, Jesús Ponce. farmindustria.